Artificial Life, Inc.
ALIF · OTC
9/30/2011 | 6/30/2011 | 3/31/2011 | 12/31/2010 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.01 | -0.01 | 0.01 |
| FCF Yield | -10.08% | -1.75% | -3.92% | -1.77% |
| EV / EBITDA | -5.32 | -6.24 | 6.53 | -10.75 |
| Quality | ||||
| ROIC | -3.00% | -7.70% | 6.04% | -9.86% |
| Gross Margin | -1,322.07% | -651.29% | 81.99% | 55.24% |
| Cash Conversion Ratio | 0.88 | 0.06 | -0.34 | -0.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -14.59% | 1.62% | 14.03% | 16.50% |
| Free Cash Flow Growth | -104.49% | 75.11% | -47.55% | 12.18% |
| Safety | ||||
| Net Debt / EBITDA | -0.31 | -0.32 | 0.10 | 0.02 |
| Interest Coverage | -175.51 | -260.22 | 204.31 | -524.43 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 12,083.85 | 7,871.20 | 170.59 | 151.84 |